Non-Melanoma Skin Cancer: Applying Multidisciplinary Care and Immunotherapy to Maximize Outcomes is organized by Med Learning Group.
Released Date: July 15, 2024
Expiration Date: July 15, 2025
Description:
This online enduring activity will identify strategies to improve multidisciplinary care for patients with advanced cutaneous squamous cell carcinoma or basal cell carcinoma, including risk assessment, communication, and patient education; discuss the latest clinical evidence for approved and investigational immunotherapeutic approaches for advanced cutaneous squamous cell carcinoma or basal cell carcinoma; and apply practice guideline recommendations for immunotherapies in patients with either cutaneous squamous cell carcinoma or basal cell carcinoma.
Learning Objectives:
Upon the completion of this program, attendees should be able to:
Joint Accreditation Statement:
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement:
Med Learning Group designates this enduring activity for a maximum of .50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nurses (ANCC) Credit Designation:
Med Learning Group designates this activity for a maximum of .50 ANCC contact hour.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved